Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Constative on MSN
The Oddest Animals Born From Human Design
Humans have long experimented with nature, bending evolution to serve aesthetics, science, and curiosity. Some animals have ...
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
Reid Hoffman Warns Silicon Valley Blind Spot Could Fuel Next AI Revolution In Healthcare And Biology
LinkedIn co-founder Reid Hoffman warns that Silicon Valley's software obsession is limiting AI opportunities in healthcare ...
Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are ...
Department of Plant Biology, Rutgers University, New Brunswick, NJ, United States CRISPR-based technologies have revolutionized plant science by enabling precise modulation of gene function, including ...
CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...
CRISPR Therapeutics is the first company to secure an FDA approval of a gene-editing drug. That drug's underlying science, however, could be used to create treatments for any number of genetically ...
Despite emerging clinical successes, current genome editors suffer from off-target effects and can trigger unwanted responses from the immune system, limiting their broader therapeutic applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results